Nelson Scientific Labs is a Maryland based biomedical research and consulting company founded in 2018. We discover, develop, and deliver biomarkers for exposure assessment, in vitro diagnostics and precision medicine. We acquire and study molecular profile data from diverse biological matrices using state-of-the-art analytic platforms for metabolomics, transcriptomics, and proteomics. We offer hope to cancer patients seeking early disease detection and health monitoring during curative radiation therapy. We aim to provide valuable solutions for personalized treatment and precision medicine that improve the cancer patient’s clinical outcome.

The mission of the company is to use personalized medicine approaches for improving clinical outcomes in cancer patients receiving curative radiation therapy. In order to attain this goal, we have developed strategic collaborations that combine inter-disciplinary programs including molecular profiling, clinical chemistry, bioinformatics and clinical care and treatment. Nelson has focused on biomarker panels for precision medicine in early detection of cancer and for prediction of radiation induced late effects and/or organ dysfunction.